7 Small-Cap Biotech Stocks with Massive Potential

06:36pm, Thursday, 27'th Apr 2023
While unproven biotechnology firms almost always carry significant risks, small-cap biotech stocks in particular typically impose jaw-dropping volatility. Along with the usual risk of clinical disappo
BOCA RATON, Fla. , April 25, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological an

7 Value Stocks to Buy for Long-Term Growth

01:50pm, Sunday, 26'th Mar 2023
For investors that have the patience to ride out volatility in exchange for possible long-term upside, value stocks to buy that are discounted against book value may offer considerable intrigue. On pa
If you aspire to one day topple entrepreneurial genius Elon Musk on the net wealth rankings through the equities market exclusively, you're obviously going to need to conduct heavy research on the sto
Sensus Healthcare quickly fell 30% after a slight miss on Q4 revenue and earnings. Actual numbers were a slight beat and only appeared to be a miss, thanks to unusual circumstances.
With thousands of publicly traded companies to choose from, it's inevitable that a few will make the rounds of overlooked value stocks. These enterprises represent businesses that trade at an attracti
Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q4 2022 Earnings Conference Call February 9, 2023 4:30 PM ET Company Participants Kim Golodetz - Lippert/Heilshorn & Associates Joseph Sardano - Co-Founder, Chai
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -34.62% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the st
BOCA RATON, Fla., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and
Sensus Healthcare, Inc. is working to recover from a tough Q3, 2022. Preliminary Q4 2022 earnings are reigniting interest in Sensus Healthcare.
Two new Breakout Stocks for Week 2 with better than 10% short-term upside potential and one Dow 30 Picks. Average cumulative returns for 2022 reached +142.69% YTD. Momentum Gauge trading signal turned
Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023
Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Kim Golodetz - Investor Relations Joe Sardano - Chairman and Chief Executive Of
Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passe
Biotech isn't the only place investors in health care stocks can make money in 2022. Take a look at leading medical-equipment stocks.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE